Research graph
References from Psilocybin. Local targets link to admitted publications; unresolved targets remain external evidence.
Adverse events in studies of classic psychedelics: a systematic review and meta-analysis.
10.1001/jamapsychiatry.2024.2546 · 2024 · External reference
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force report: serotonergic psychedelic treatments for major depressive disorder.
10.1177/07067437221111371 · 2023 · External reference
Single-dose psilocybin treatment for major depressive disorder: a randomized clinical trial.
10.1001/jama.2023.14530 · 2023 · External reference
Single-dose psilocybin for a treatment-resistant episode of major depression.
10.1056/nejmoa2206443 · 2022 · External reference
Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: a living systematic review with meta-analysis.
10.1016/j.euroneuro.2025.09.011 · 2025 · External reference
Psilocybin or nicotine patch for smoking cessation: a pilot randomized clinical trial.
10.1001/jamanetworkopen.2026.0972 · 2026 · External reference
Acute adverse effects of therapeutic doses of psilocybin: a systematic review and meta-analysis.
10.1001/jamanetworkopen.2024.5960 · 2024 · External reference
Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.
10.1177/20451253251372449 · 2025 · External reference
Blinding integrity in psychedelic randomized clinical trials: a systematic review.
10.1001/jamapsychiatry.2026.0255 · 2026 · External reference
Psychological therapy quantity and depressive symptom reduction in psychedelic-assisted therapy: a systematic review and meta-analysis.
10.1001/jamanetworkopen.2025.54843 · 2026 · External reference
